(Q1829318)

English

dolasetron

pharmaceutical drug

Statements

324.1473925 dalton
C₁₉H₂₀N₂O₃
1 reference
O=C(OC1CC2CC3CC(C1)N2CC3=O)c1c[nH]c2ccccc12
O=C(O[C@H]1C[C@@H]2C[C@@H]3C[C@@H](C1)N2CC3=O)C4=CNC5=C4C=CC=C5
O=C(O[C@@H]1C[C@@H]2C[C@H]3C[C@H](C1)N2CC3=O)c4c[nH]c5ccccc45
1 reference
0 references
0 references
0 references

Identifiers

1 reference
28 October 2019
DOLASETRON (English)
10 May 2021
601-402-4
1 reference
27 December 2018
1H-Indole-3-carboxylic acid, (6R,9aS)-octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, rel- (English)
CAS no.: 115956-12-2 (English)
1 reference
27 December 2018
1H-Indole-3-carboxylic acid, (6R,9aS)-octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, rel- (English)
CAS no.: 115956-12-2 (English)
 
edit
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit